West Dedicates Manufacturing Plant in India
PTSM: Pharmaceutical Technology Sourcing and Management
West's new plant in India will manufacture primary packaging for injectable drugs.
West has dedicated its first manufacturing plant in India, located in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary packaging for injectable medicines business.
"This new facility in Sri City will allow West to continue to satisfy the needs of our customers, who are serving a growing number of patients in India and the Asia Pacific region,” said Donald E. Morel, Jr., West’s chairman and CEO, in a press release.
The 15,300-m
2
(approximately 164,700-ft
2
) facility will produce seals used in primary packaging of injectable medicines manufactured by West’s pharmaceutical and biopharmaceutical customers in India and the wider Asia Pacific region. There are future plans to expand production at the site to include West’s elastomer component business. West’s manufacturing presence in the Asia Pacific market also includes a plant in Singapore and two plants in Qingpu, China.
Source: West
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
